TCL Archive JCO Retracts Key Duke Genomics Paper; Duke Shuts Down Three Phase II Trials November 19, 2010
TCL Archive Merck Serono Cancels Tecemotide Program In NSCLC, Including Two Phase III Trials September 26, 2014